| Dr Kevin R Mcdonald, MD | |
|
2214 Canterbury Dr, Suite 308, Hays, KS 67601-2386 | |
| (785) 628-6014 | |
| (785) 628-6094 |
| Full Name | Dr Kevin R Mcdonald |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 46 Years |
| Location | 2214 Canterbury Dr, Hays, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548362866 | NPI | - | NPPES |
| 35043015 | Other | MO | BCBS KANSAS CITY |
| 614870 | Other | KS | FIRSTGUARD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 04-18425 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hays Medical Center | Hays, KS | Hospital |
| Rooks County Health Center | Plainville, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hays Medical Center Inc | 1557279676 | 158 |
News Archive
Vermillion, a molecular diagnostics company, today announced that it has signed an agreement with Quest Diagnostics to make OVA1 available in India. The companies are targeting a launch in the second quarter of 2011. Additionally, at the International Gynecologic Cancer Society (IGCS) regional meeting held in New Delhi April 2-3, 2011, Dr. Fred Ueland presented data demonstrating the high sensitivity for ovarian malignancy of OVA1 in combination with ultrasound.
The goal is to make human eggs, ovarian tissue, blood vessels, even whole organs available when needed.
The Sbarro Health Research Organization (SHRO), a nonprofit research facility located at Temple University, will dedicate a new state-of-the-art biotechnology research center on Tuesday, October 27th, at 2 p.m. SHRO is one of the top three international laboratories, based on number of publications as ranked by the Cell Cycle Registry,
A Mayo Clinic research study published in the January issue of the American Journal of Gastroenterology finds that St. John's wort is not an effective treatment for irritable bowel syndrome (IBS). While antidepressants are frequently used to treat IBS, to date, no study has examined the success of using the herbal supplement St. John's wort in treating IBS.
› Verified 9 days ago
| Entity Name | Hays Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770618258 PECOS PAC ID: 1557279676 Enrollment ID: O20040224000687 |
News Archive
Vermillion, a molecular diagnostics company, today announced that it has signed an agreement with Quest Diagnostics to make OVA1 available in India. The companies are targeting a launch in the second quarter of 2011. Additionally, at the International Gynecologic Cancer Society (IGCS) regional meeting held in New Delhi April 2-3, 2011, Dr. Fred Ueland presented data demonstrating the high sensitivity for ovarian malignancy of OVA1 in combination with ultrasound.
The goal is to make human eggs, ovarian tissue, blood vessels, even whole organs available when needed.
The Sbarro Health Research Organization (SHRO), a nonprofit research facility located at Temple University, will dedicate a new state-of-the-art biotechnology research center on Tuesday, October 27th, at 2 p.m. SHRO is one of the top three international laboratories, based on number of publications as ranked by the Cell Cycle Registry,
A Mayo Clinic research study published in the January issue of the American Journal of Gastroenterology finds that St. John's wort is not an effective treatment for irritable bowel syndrome (IBS). While antidepressants are frequently used to treat IBS, to date, no study has examined the success of using the herbal supplement St. John's wort in treating IBS.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kevin R Mcdonald, MD 2214 Canterbury Dr, Suite 308, Hays, KS 67601-2386 Ph: (785) 628-6014 | Dr Kevin R Mcdonald, MD 2214 Canterbury Dr, Suite 308, Hays, KS 67601-2386 Ph: (785) 628-6014 |
News Archive
Vermillion, a molecular diagnostics company, today announced that it has signed an agreement with Quest Diagnostics to make OVA1 available in India. The companies are targeting a launch in the second quarter of 2011. Additionally, at the International Gynecologic Cancer Society (IGCS) regional meeting held in New Delhi April 2-3, 2011, Dr. Fred Ueland presented data demonstrating the high sensitivity for ovarian malignancy of OVA1 in combination with ultrasound.
The goal is to make human eggs, ovarian tissue, blood vessels, even whole organs available when needed.
The Sbarro Health Research Organization (SHRO), a nonprofit research facility located at Temple University, will dedicate a new state-of-the-art biotechnology research center on Tuesday, October 27th, at 2 p.m. SHRO is one of the top three international laboratories, based on number of publications as ranked by the Cell Cycle Registry,
A Mayo Clinic research study published in the January issue of the American Journal of Gastroenterology finds that St. John's wort is not an effective treatment for irritable bowel syndrome (IBS). While antidepressants are frequently used to treat IBS, to date, no study has examined the success of using the herbal supplement St. John's wort in treating IBS.
› Verified 9 days ago
Darrell D Werth, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 2214 Canterbury Dr, Suite 308, Hays, KS 67601 Phone: 785-628-6014 Fax: 785-628-6094 | |
Faris Sabri Azzouni, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2214 Canterbury Dr, Suite 308, Hays, KS 67601 Phone: 785-628-6014 Fax: 785-628-6094 | |
Ernesto Lopez-corona, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 2214 Canterbury Dr, Suite 308, Hays, KS 67601 Phone: 785-628-6014 Fax: 785-628-6094 | |
Subrahmanyeswara Srinivas Samavedi, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2214 Canterbury Dr Ste 308, Hays, KS 67601 Phone: 785-628-6014 Fax: 785-628-6094 |